What Is GHK-Cu? The Copper Peptide Explained for Women Over 40

By the Amsara Health team · Clinical review: Mia Chorney, DNP, MSCP · Updated October 2026

GHK-Cu is a naturally occurring copper peptide: three amino acids (glycine, histidine, lysine) bound to a copper ion. Your body makes it, your blood levels fall by more than half between age 20 and 60, and in the skin it signals fibroblasts to rebuild collagen, elastin, and the water-binding molecules that keep skin firm. That is why it is the base ingredient in both Amsara Beauty prescription face creams.

What is GHK-Cu, exactly?

GHK-Cu is a tripeptide, a chain of three amino acids: glycine, histidine, and lysine. On its own that chain is called GHK. When it binds a copper ion (Cu²⁺), it becomes GHK-Cu, the form most skincare refers to as “copper peptide.” The complex is small, with a molecular weight of about 403 daltons, and it is water-loving rather than oil-loving, which, as we will see, shapes how it has to be formulated to reach living skin cells.

It is not a synthetic invention. GHK was first identified in human plasma in 1973, and a 2025 review in Biomolecules describes it as a natural fragment of the collagen alpha chain. In other words, when collagen is broken down, GHK is one of the pieces released, and that fragment acts as a messenger telling nearby cells that repair is needed. Copper is part of the message: it is a required cofactor for lysyl oxidase, the enzyme that cross-links new collagen and elastin, and for superoxide dismutase, one of the skin’s own antioxidant enzymes.

Why does GHK-Cu matter more after 40?

Two things change at the same time in midlife. The first is the supply of GHK itself. The Frontiers in Aging review reports plasma GHK of about 200 ng/mL at age 20 declining to about 80 ng/mL at age 60, a drop of roughly 60%. The authors link that decline to slower skin repair and faster visible aging.

The second is estrogen. Facial skin carries a high concentration of estrogen receptors, and as estrogen falls through perimenopause and menopause, collagen production falls with it. The 2025 EMJ Dermatology clinician’s review puts the loss at about 30% of skin collagen in the first five years after menopause, and notes that the loss tracks the duration of estrogen deficiency more closely than chronological age. The result is the thinning, dryness, and crepiness so many women notice in their late 40s and 50s, often before they connect it to hormones. We cover that connection in depth in HRT Is Only Part of the Solution.

So the skin of a woman at 52 is working with less of its own repair signal and less of the hormone that drives collagen synthesis. GHK-Cu addresses the first problem directly. It does not address the second, which is why Amsara pairs it with topical estriol rather than using it alone.

How does GHK-Cu work in the skin?

Most skincare actives do one thing. Retinoids speed cell turnover. Vitamin C donates electrons. GHK-Cu behaves differently: it changes which genes skin cells switch on. The Frontiers in Aging authors describe it as modulating approximately 31% of human genes, upregulating antioxidant defense, DNA repair, and tissue-remodeling pathways while turning down inflammatory and pro-fibrotic ones. They are careful to note that this has been shown in cells and dermal models, and that its full significance in living human skin still needs controlled studies.

Within that broad signal, the laboratory literature summarized in the Biomolecules and International Journal of Medical Sciences reviews points to four actions that matter for aging skin:

• It stimulates fibroblasts to produce collagen, elastin, and glycosaminoglycans, the molecules that give the dermis its structure and hold water.
• It protects what you already have. GHK-Cu increases tissue inhibitors of metalloproteinases (TIMPs) and inhibits elastase, which slows the enzymes that break down collagen and elastin after sun exposure and inflammation.
• It calms inflammation. In cell studies it reduced the inflammatory messengers TNF-α and IL-6 by quieting the NF-κB pathway.
• It supports repair and blood supply. GHK-Cu attracts repair cells to a wound site and promotes new capillary growth, which is why it was studied for wound healing long before it appeared in face creams.

What does the clinical research actually show?

This is where an honest answer matters, because GHK-Cu is heavily marketed and the human trials are smaller than the marketing implies. Here is what has been published, as summarized in the 2025 BioImpacts review of topical GHK as an anti-wrinkle peptide and the 2026 Aesthetic Surgery Journal systematic review:

• Facial cream, 71 women, 12 weeks (Leyden et al.). Compared with placebo, the GHK-Cu cream increased skin density and thickness and reduced laxity, fine lines, and wrinkle depth in women with photodamaged skin.
• Eye cream, 41 women, 12 weeks (Leyden et al.). GHK-Cu outperformed both placebo and a vitamin K cream on lines, wrinkles, and skin thickness.
• Collagen production, 20 volunteers, one month (Abdulghani et al.). New procollagen synthesis increased in 70% of people using GHK-Cu, compared with 50% using vitamin C and 40% using retinoic acid.
• Head-to-head serum, 8 weeks (Badenhorst et al.). Wrinkle depth fell significantly more with a GHK-Cu serum than with the vehicle alone or a commercial serum built on Matrixyl 3000, per the Biomolecules review.
• Systematic review, 20 studies through March 2026 (Mokhtar et al.). Eighteen preclinical studies and two randomized controlled trials. The authors found GHK-Cu increased type I collagen and glycosaminoglycan production, modulated metalloproteinase activity, and reduced wrinkle depth and volume more than controls. Their conclusion: biologically plausible and promising, but the field needs larger trials with standardized formulas, doses, and delivery.

Our read is the same as theirs. The direction of the evidence is consistent across cell, animal, and human studies, and GHK-Cu has an unusually long safety record for a cosmetic active. But the human trials are small and many are two decades old. GHK-Cu is a well-supported ingredient, not a miracle, and anyone promising a specific percentage improvement from a copper peptide alone is reaching past the data.

Is GHK-Cu safe?

Topically, GHK-Cu has a reassuring profile. The International Journal of Medical Sciences review reports no cytotoxicity to primary human cells from GHK-complexed copper, and GHK has been assessed as safe for cosmetic use at the concentrations found in products. It is non-irritating for most people and is generally well tolerated on sensitive skin, which is one reason it is often recommended to women who find retinoids too harsh.

Two caveats belong here. First, the BioImpacts authors note that no studies have been published specifically on side effects of topical GHK peptides, and the Frontiers in Aging authors list systemic safety as unknown. That is a statement about missing data, not about observed harm, but it is worth knowing. Second, the common-sense rules apply: do not apply it to broken skin, avoid the eye area unless the product is designed for it, and stop and call your provider if you develop redness or itching. In a prescription cream like Restore or Revive, your provider also screens the other ingredients, which matters more than the GHK-Cu itself (see who should not use an estriol cream below).

GHK-Cu vs. retinol vs. vitamin C: how do they compare?

These three are not competitors so much as different tools. Retinoids (tretinoin, retinol) have the deepest evidence base for wrinkles and photodamage, but they work by accelerating turnover and commonly cause dryness and peeling, which thinning menopausal skin tolerates poorly. Vitamin C is an antioxidant that also supports collagen synthesis, but it is unstable and acidic. GHK-Cu works upstream, as a signal to rebuild and protect, and it is gentle enough for daily use on reactive skin.

Can you use them together? Yes, with one practical note. Because GHK-Cu carries copper and vitamin C is a strong acid, many formulators advise applying them at different times of day (vitamin C in the morning under sunscreen, copper peptide at night) rather than layering them in the same minute. Retinoids and GHK-Cu are commonly alternated or layered without issue, but if you are on prescription tretinoin, tell your Amsara provider so the routine can be sequenced for you.

Why do over-the-counter copper peptide serums vary so much?

Because getting GHK-Cu through the skin barrier is hard, and most labels tell you nothing about whether the product does. A 2025 paper in Molecules describes GHK-Cu as “a fairly hydrophilic compound with limited permeation through the lipophilic stratum corneum,” meaning a water-loving molecule trying to cross an oily barrier. In laboratory skin models, only about 3.9% of applied GHK-Cu permeated over 24 hours, according to data summarized in the BioImpacts review.

Formulation closes that gap. Liposomal and microemulsion carriers, penetration enhancers, and a cream base that keeps the copper complex stable all change how much active reaches the dermis. Oxidation is the main threat to stability, which is why serious GHK-Cu products come in airless or opaque packaging. Over-the-counter serums rarely disclose concentration, carrier, or stability data, so two bottles with “copper peptide” on the label can perform very differently. A compounded prescription cream is made to a specified formula by a licensed pharmacy, which removes most of that guesswork.

Why pair GHK-Cu with estriol for menopause skin?

GHK-Cu tells skin to rebuild. Estriol gives it the hormonal support to answer. Estriol is the mildest of the three human estrogens, and applied to facial skin it acts locally on the estrogen receptors that lost their signal at menopause. A 2026 review in JAAD Reviews summarizes the trials: in the best-known one, 59 women used either 0.01% estradiol or 0.3% estriol on the face for six months, and both groups showed increased collagen and significantly improved wrinkles, with estriol reaching P < .0005. The same review notes that most prescription compounded anti-aging creams use 0.3% estriol, and that safety data on long-term use remain limited, which is why these creams belong under a provider’s supervision rather than on an open shelf.

Together, the two actives address both halves of the midlife skin problem described earlier: less repair signal and less estrogen. That is the logic behind every formula on the Amsara Beauty page. For the full picture of how topical estriol relates to hormone replacement therapy, read HRT Is Only Part of the Solution.

Who should not use a GHK-Cu and estriol face cream?

GHK-Cu itself has few restrictions. The estriol is what requires screening. Restore and Revive are not used during pregnancy or breastfeeding, and they are generally not appropriate for women with a history of estrogen-sensitive cancer, unexplained vaginal bleeding, or blood clots unless a provider decides otherwise after reviewing your history. Women with a uterus who are also on systemic hormone therapy should discuss progesterone with their provider. Compounded medications are not FDA-approved, and the FDA has not evaluated them for safety, effectiveness, or quality; Amsara works only with licensed pharmacy partners and prescribes them only when clinically indicated.

How Amsara Health uses GHK-Cu: Restore and Revive Face Cream

Both Amsara Beauty creams are built on GHK-Cu and micronized estriol, compounded to order by Optimal Balance Pharmacy, and prescribed only after a telehealth visit with an Amsara provider. They ship in a 30 mL airless jar that protects the copper complex from light and air, and a pea-sized amount applied once daily is about a 90-day supply when applied as directed.

• Restore Face Cream pairs GHK-Cu and micronized estriol with niacinamide, sodium hyaluronate, DMAE, and panthenol for the thinning, dryness, and crepiness that arrive with perimenopause and menopause. $179 for non-members, which includes the initial provider visit and the compounded prescription when clinically indicated; $119 for members.
• Revive Face Cream is the Restore formula plus acetyl hexapeptide-8 (SNAP-8), a surface-acting peptide that softens the look of expression lines on the forehead, between the brows, and around the eyes and mouth. $269 for non-members, visit included; $199 for members.

Here is how it works. New patients book a skincare visit with Dr. Mia Chorney, who sees patients Tuesday through Thursday, 9:00 a.m. to 4:00 p.m. Arizona time. She reviews your skin goals, hormone status, and health history and selects a formula, or discusses alternatives if a cream is not right for you. The pharmacy compounds it and ships it directly to you, with free shipping in Arizona for members and non-members. Renewals are requested through the Patient Portal and are free for members. Prescriptions may qualify for HSA or FSA reimbursement. Not sure which formula fits? The Midlife Skin Check takes about 90 seconds. Outside Arizona? Join the waitlist through our discovery call page.

Frequently asked questions

Sources

Mavrych V, et al. Therapeutic peptides in gerontology: mechanisms and applications for healthy aging. Frontiers in Aging, 2026. · Mokhtar J, et al. The Regenerative Potential of GHK-Cu in Aesthetic Medicine. Aesthetic Surgery Journal, 2026. · Troxel J, et al. Topical estrogen therapy for aging skin: current evidence and clinical considerations. JAAD Reviews, 2026. · Mortazavi SM, et al. Topically applied GHK as an anti-wrinkle peptide: advantages, problems and prospective. BioImpacts, 2025. · Pintea A, et al. Peptides: emerging candidates for the prevention and treatment of skin senescence. Biomolecules, 2025. · Adnan SB, et al. Exploring the role of tripeptides in wound healing and skin regeneration. International Journal of Medical Sciences, 2025. · Ogórek K, et al. Are we ready to measure skin permeation of modern antiaging GHK-Cu tripeptide encapsulated in liposomes? Molecules, 2025. · DeGiovanni C. Managing menopausal skin: a clinician’s review. EMJ Dermatology, 2025.

This article is for education and does not replace individual medical advice. Restore and Revive Face Cream are compounded prescription medications available to Amsara Health patients in Arizona when clinically indicated. Compounded medications are not FDA-approved, and the FDA has not evaluated them for safety, effectiveness, or quality. Results vary.

---

Ready to give your skin its own prescription?

Skincare visits with Dr. Mia Chorney, Tuesday through Thursday. Compounded for you. Free shipping in Arizona for members and non-members.

Already a patient? Ask your provider about prescription skincare through the Amsara Patient Portal.